High costs and shortages are driving demand for unregulated GLP-1 drugs, prompting FDA alerts about counterfeit Ozempic and calls for stricter enforcement by legal experts.
While DTC telehealth companies remove barriers to care for patients, questions remain regarding patient safety and proper education of these products.
YouTube on MSN
HTC Google Nexus 9
Explore the features and capabilities of the HTC Google Nexus 9 in this detailed review! Discover how this innovative tablet, ...
Celcuity Inc. surges to a $2B valuation on strong phase 3 data for gedatolisib in hormone-positive breast cancer. Read why ...
The latest announcement is out from PharmAla Biotech Holdings, Inc. ( ($TSE:MDMA) ). PharmAla Biotech Holdings Inc. has launched NEXUS, a ...
This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback